Understanding Prognosis Based on Tumor Genetic Mutations in Cancer Outcomes
Tumor genetic mutations have become a pivotal component in understanding the prognosis of mesothelioma, offering insights into disease progression and patient outcomes. Advancements in genetic profiling are transforming how clinicians predict, monitor, and tailor treatments for asbestos-related malignancies, raising important questions about the role of molecular data in prognosis based on tumor genetic mutations. Understanding … Read more